The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had to be scrapped last year. By Chris Hamby, Sharon LaFraniere and Sheryl Gay Stolberg from NYT U.S. https://ift.tt/3fM7UeR